TG THERAPEUTICS, INC. Other Non-Current Assets
TG THERAPEUTICS, INC. (TGTX) had Other Non-Current Assets of $2.21 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Noncurrent $2.21M.
- 2026-03-31: Other Assets, Noncurrent $2.02M.
- 2025-12-31: Other Assets, Noncurrent $2.04M.
- 2025-09-30: Other Assets, Noncurrent $2.04M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $2.21M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $2.02M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.04M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.03M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.04M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.07M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.11M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.15M 10-Q · filed 2024-08-09 |
| 2023-12-31 | $2.31M 10-K · filed 2025-03-03 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2017-03-31 | $110.07K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $164.38K 10-K · filed 2018-03-15 |
| 2016-09-30 | $127.70K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $127.70K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $173.84K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $171.18K 10-K · filed 2017-03-16 |
| 2015-09-30 | $141.72K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $155.56K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $130.63K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $137.10K 10-K · filed 2016-03-15 |
| 2014-09-30 | $71.25K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $98.36K 10-Q · filed 2014-07-24 |
| 2014-03-31 | $76.42K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $85.12K 10-K · filed 2015-03-16 |
| 2013-09-30 | $85.12K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $90.06K 10-Q · filed 2013-08-09 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-07 |
| 2011-09-30 | $7.75K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $7.75K 10-Q/A · filed 2011-09-14 |
| 2010-12-31 | $21.37K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |